We’re very excited to have Mr. Brent Charleton, the Senior Vice President Business Development at EnWave Corporation (TSXV:ENW – $1.07 CAD & OTC:NWVCF – $0.76 USD & Frankfurt:E4U – €0.74), as our guest today. EnWave continues to make significant progress in the food and pharmaceutical markets with its revolutionary drying technology.
The interview touches upon EnWave’s first quarter financial results and provides an outlook for the rest of the year. Mr. Charleton touches upon EnWave’s royalty income as he gives an overview of REV-dried products that are already on the market, and as such generating royalties for EnWave.
Mr. Charleton also talks about the reorganization at NutraDried LLC, in which EnWave holds a 51% stake, and which produces the well-known Moon Cheese snacks.
A substantial portion of the interview is devoted to EnWave’s most advanced customers, such as the Turkish company Ereğli Agrosan and the Chilean fruit processor Natural Nutrition. In addition, Mr. Charleton gives a substantial update on Bonduelle and its InFlavor REV-dried vegetables.
The interview also digs deeper into the pharmaceutical side of the business, where EnWave currently has two partners, Merck and Sutro Biopharma. Listeners also find out if there are more pharmaceutical partners in the pipeline.
Access our interview by clicking the play button on the media player below,
or download our convenient transcript.
|Smallcaps.us Advice: Buy||Price Target: $3.44||Latest Company Report (pdf)|
|For important disclosures, please read our disclaimer.|